Short Interest in Propanc Biopharma, Inc. (OTCMKTS:PPCB) Drops By 46.4%

Propanc Biopharma, Inc. (OTCMKTS:PPCB) was the target of a large drop in short interest in the month of August. As of August 31st, there was short interest totalling 1,550,100 shares, a drop of 46.4% from the August 15th total of 2,893,800 shares. Based on an average daily trading volume, of 20,058,900 shares, the days-to-cover ratio is presently 0.1 days.

Propanc Biopharma Trading Down 20.0 %

Propanc Biopharma stock opened at $0.00 on Friday. Propanc Biopharma has a twelve month low of $0.00 and a twelve month high of $0.04.

Propanc Biopharma Company Profile

Propanc Biopharma, Inc, a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. It offers PRP, a formulation lead product that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes.